Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC

ClinicalTrials.gov ID: NCT00432185

Public ClinicalTrials.gov record NCT00432185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multi-center, Dose-escalation, Cohort Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel Given as Either a Single Application (on Day 1) or as Two Applications (on Day 1 and Day 8) to a Superficial Basal Cell Carcinoma (sBCC) on the Trunk.

Study identification

NCT ID
NCT00432185
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Peplin
Industry
Enrollment
117 participants

Conditions and interventions

Interventions

  • PEP005 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2007
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Feb 14, 2016

2007 – 2010

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Alta Dermatology Mesa Arizona 85206
Dermatology Specialists Inc. Oceanside California 92056
Skin Surgery Medical Group Inc. San Diego California 92117
Colorado Medical Research Center Denver Colorado 80210
Advanced Dermatology and Cosmetic Surgery Clermont Florida 34711
Park Avenue Dermatology Orange Park Florida 32073
Minnesota Clinical Studies Center Fridley Minnesota 55421
Dermatology Associates of Rochester Rochester New York 14623
Rivergate Dermatology and Skin Care Center Goodlettsville Tennessee 37072

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00432185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2016 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00432185 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →